NLU Meghalaya Library

Online Public Access Catalogue (OPAC)

NEW DRUGS, FAIR PRICES (Record no. 5274)

MARC details
000 -LEADER
fixed length control field 03276cam a2200493M 4500
001 - CONTROL NUMBER
control field 9781003330271
003 - CONTROL NUMBER IDENTIFIER
control field FlBoTFG
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240213122827.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |n|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 221005s2022 xx o 0|| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency OCoLC-P
Language of cataloging eng
Transcribing agency OCoLC-P
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781000781243
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1000781240
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781003330271
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1003330274
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781000781298
Qualifying information (electronic bk. : EPUB)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1000781291
Qualifying information (electronic bk. : EPUB)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 103235223X
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781032352237
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781032361055
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 1032361050
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.4324/9781003330271
Source of number or code doi
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1346535953
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC-P)1346535953
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number HD9666.5
072 #7 - SUBJECT CATEGORY CODE
Subject category code BUS
Subject category code subdivision 070130
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code BUS
Subject category code subdivision 070170
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code BUS
Subject category code subdivision 108000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code KJMV6
Source bicssc
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 338.4/361510973
Edition number 23/eng/20220527
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Smith, Brian D.
Titles and words associated with a name (Author of New drugs, fair prices),
Relator term author.
245 10 - TITLE STATEMENT
Title NEW DRUGS, FAIR PRICES
Medium [electronic resource] :
Remainder of title managing the pharmaceutical innovation ecosystem for... sustainable and affordable new medicines.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. [S.l.] :
Name of publisher, distributor, etc. ROUTLEDGE,
Date of publication, distribution, etc. 2022.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource
520 ## - SUMMARY, ETC.
Summary, etc. New Drugs, Fair Prices addresses the important question of how we might get the innovative new medicines we need at prices we can afford. Today, this debate is impassioned but sterile. One side calls for price controls, discounting their impact on investment in innovation. The other points to miraculous new therapies, disregarding their affordability and social inequity. This polarized argument creates more heat than light, threatening the social contract between the industry and society on which pharmaceutical innovation depends. This ground-breaking book takes a wholly new perspective on the issue and raises the debate to a more informed and productive level. Drawing on interviews with more than 70 experts across the pharmaceutical innovation world and combining a diverse literature from scientific, political, economic and business domains, it describes how a sustainable and affordable supply of new medicines is possible only by balancing pharmaceutical innovation's complex, adaptive ecosystem. By considering how each of the ecosystem's seven habitats work and interact with the others, it makes a comprehensive set of recommendations for achieving that ecosystem balance. The core message of New Drugs, Fair Prices is important to anyone who ever has needed or will ever need a medicine: we can have a sustainable supply of new medicines that are both innovative and affordable if we manage the pharmaceutical innovation ecosystem intelligently.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note OCLC-licensed vendor bibliographic record.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
General subdivision Prices
Geographic subdivision United States.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prescription pricing
Geographic subdivision United States.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmaceutical industry
Geographic subdivision United States.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
Geographic subdivision United States
General subdivision Cost control.
856 40 - ELECTRONIC LOCATION AND ACCESS
Materials specified Taylor & Francis
Uniform Resource Identifier <a href="https://www.taylorfrancis.com/books/9781003330271">https://www.taylorfrancis.com/books/9781003330271</a>
856 42 - ELECTRONIC LOCATION AND ACCESS
Materials specified OCLC metadata license agreement
Uniform Resource Identifier <a href="http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf">http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf</a>

No items available.